5BJT
Crystal structure of human FcRn with a peptide inhibitor at multiple sites
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-BM |
Synchrotron site | APS |
Beamline | 22-BM |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-10-31 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 1.0 |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 104.917, 176.152, 245.515 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 49.270 - 3.200 |
R-factor | 0.257 |
Rwork | 0.252 |
R-free | 0.33900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3m17 |
RMSD bond length | 0.018 |
RMSD bond angle | 1.965 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0072) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 3.310 |
High resolution limit [Å] | 3.200 | 3.200 |
Rmerge | 0.111 | 0.718 |
Number of reflections | 37736 | |
<I/σ(I)> | 16.6 | 2.7 |
Completeness [%] | 99.9 | 100 |
Redundancy | 5.6 | 5.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 4.7 | 277 | 1.6 M ammonium sulfate, 20% glycerol, 0.8 M sodium acetate |